Abstract

The article discusses the role of topical glucocorticosteroids in treatment of children suffering from atopic dermatitis as well as problems of clinical efficacy and safety of application of mometasone furoate (Elocom®) for this dermatosis during the period of exacerbation.

Highlights

  • The article discusses the role of topical glucocorticosteroids in treatment of children suffering from atopic dermatitis as well as problems of clinical efficacy and safety of application of mometasone furoate (Elocom®) for this dermatosis during the period of exacerbation

  • Мометазона фуроат (Элоком®) представляет собой высокоэффективный и безопасный препарат, не имеющий возрастных ограничений для применения, который целесообразно использовать у детей в период обострения атопического дерматита

Read more

Summary

Introduction

О роли топических глюкокортикостероидов в лечении атопического дерматита у детей On the role of topical glucocorticosteroids in treatment of atopic dermatitis in children Обсуждается роль топических глюкокортикостероидов в лечении детей, больных атопическим дерматитом, а также вопросы клинической эффективности и безопасности применения мометазона фуроата (Элоком®) при данном дерматозе в период обострения.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.